Autumn Glory Partners LLC Purchases 662 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Autumn Glory Partners LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 121.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,207 shares of the healthcare conglomerate’s stock after buying an additional 662 shares during the period. Autumn Glory Partners LLC’s holdings in UnitedHealth Group were worth $707,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC raised its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on UNH. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Barclays cut their price target on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 0.2 %

NYSE:UNH opened at $565.46 on Tuesday. The company has a market cap of $522.16 billion, a PE ratio of 36.84, a PEG ratio of 1.66 and a beta of 0.58. The stock has a 50-day simple moving average of $583.25 and a 200 day simple moving average of $539.45. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 earnings per share. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.